Africa’s second-richest billionaire takes full control of major private hospital network in $947 million deal
South African billionaire Johann Rupert has strengthened his grip on the country’s private healthcare industry after investment holding company Remgro completed its $947 million (R15.56 billion) acquisition of full ownership of Mediclinic Southern Africa.
The transaction, finalised on July 1 after receiving all required regulatory approvals, gives Remgro sole ownership of one of Southern Africa’s largest private hospital groups, ending a long-standing joint ownership structure with Luxembourg-based Investment Holding Limited (IHL).
Before the restructuring, Remgro and IHL each owned 50% of Mediclinic Holdings.
Under the agreement, Remgro assumes full ownership of Mediclinic’s Southern African operations through Mediclinic International, while IHL takes complete ownership of the group’s Swiss business, Hirslanden.
The separation allows both shareholders to pursue independent strategies tailored to their respective markets without the complexity of shared governance.
Remgro paid $947 million for the Southern African assets, slightly below the $950 million initially announced in December 2025 after adjustments for agreed leakages and accruals. IHL paid $1.08 billion (R17.74 billion) for the Swiss operations.
The deal follows approval by South Africa’s Competition Tribunal in June, subject to employment-related conditions, clearing the final major regulatory hurdle.
Mediclinic Southern Africa operates one of the region’s largest private healthcare networks, with approximately 50 private hospitals, day clinics, sub-acute facilities, mental health centres, the Intercare primary healthcare business and emergency medical services provider ER24 across South Africa, Namibia and Mauritius.
A bigger bet on healthcare
The acquisition deepens Remgro’s exposure to one of South Africa’s most resilient industries.
Private healthcare has remained one of the country’s strongest long-term investment themes, supported by rising demand from insured patients, population growth and persistent pressure on the public healthcare system.
The transaction also comes at a pivotal moment for the industry.
South Africa is moving ahead with the implementation of its National Health Insurance (NHI) programme, a reform that could reshape how private healthcare providers operate over the coming years.
While many details remain under discussion, hospital operators are preparing for significant regulatory and funding changes as the government seeks to expand universal healthcare coverage.
Against that backdrop, Rupert’s decision to increase his exposure suggests confidence that demand for quality private healthcare will remain strong despite policy uncertainty.
Remgro has consistently identified healthcare as one of its core long-term investment sectors alongside banking, financial services, consumer products and infrastructure.
The acquisition also simplifies Mediclinic’s ownership structure, giving management greater flexibility to pursue investments, partnerships and expansion opportunities focused exclusively on Southern Africa.
Rupert, whose fortune is estimated at about $20 billion, controls Remgro through the Rupert family’s investment vehicle, Compagnie Financière Rupert, which owns a controlling economic interest in the investment group.
About The Author
